靈北製藥 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "靈北製藥" in Chinese language version.

refsWebsite

Global rank Chinese rank

9web.archive.org

1^st place

1^st place

low place

low place

2genengnews.com

low place

low place

1shareholder.com

6,233^rd place

2,792^nd place

49^th place

81^st place

low place

low place

79^th place

143^rd place

cphpost.dk

Execution drug still available after Lundbeck shuns ‘end user’ agreements. The Copenhagen Post. 1 April 2011 [3 July 2011]. （原始内容存档于7 August 2011）.

genengnews.com

H. Lundbeck Acquiring Chelsea Therapeutics for Up to $658M. May 8, 2014 [2021-06-18]. （原始内容存档于2021-06-27）.
存档副本. [2021-06-18]. （原始内容存档于2018-09-29）.

lundbeck.com

lundbeck.com

Facts and background. lundbeck.com. [2021-04-07]. （原始内容存档于2021-04-07）. 引用错误：带有name属性“lundbeck.com”的<ref>标签用不同内容定义了多次
Facts and background. lundbeck.com. [2021-04-07]. （原始内容存档于2021-04-07）.

investor.lundbeck.com

Annual Report 2017. Lundbeck. [7 February 2018]. （原始内容存档于19 July 2018）.

reuters.com

uk.reuters.com

Lundbeck buys Alder for $2 billion, eyes 'blockbuster' migraine therapy. September 16, 2019 [2021-06-18]. （原始内容存档于2019-09-17）.

shareholder.com

files.shareholder.com

H. Lundbeck A/S. Corporate Release No 487. Lundbeck to divest a portfolio of non-core products as part of its strategy to focus on newer, strategic CNS-products (PDF). December 14, 2012 [29 July 2014]. （原始内容存档 (PDF)于2016-03-03）.

web.archive.org

Annual Report 2017. Lundbeck. [7 February 2018]. （原始内容存档于19 July 2018）.
Facts and background. lundbeck.com. [2021-04-07]. （原始内容存档于2021-04-07）. 引用错误：带有name属性“lundbeck.com”的<ref>标签用不同内容定义了多次
Facts and background. lundbeck.com. [2021-04-07]. （原始内容存档于2021-04-07）.
H. Lundbeck A/S. Corporate Release No 487. Lundbeck to divest a portfolio of non-core products as part of its strategy to focus on newer, strategic CNS-products (PDF). December 14, 2012 [29 July 2014]. （原始内容存档 (PDF)于2016-03-03）.
H. Lundbeck Acquiring Chelsea Therapeutics for Up to $658M. May 8, 2014 [2021-06-18]. （原始内容存档于2021-06-27）.
存档副本. [2021-06-18]. （原始内容存档于2018-09-29）.
Lundbeck buys Alder for $2 billion, eyes 'blockbuster' migraine therapy. September 16, 2019 [2021-06-18]. （原始内容存档于2019-09-17）.
Execution drug still available after Lundbeck shuns ‘end user’ agreements. The Copenhagen Post. 1 April 2011 [3 July 2011]. （原始内容存档于7 August 2011）.
Lundbeck Seeks to Curb Use of Drug in Executions. The Wall Street Journal. 1 July 2011 [3 July 2011]. （原始内容存档于2016-01-02）.

wsj.com

Lundbeck Seeks to Curb Use of Drug in Executions. The Wall Street Journal. 1 July 2011 [3 July 2011]. （原始内容存档于2016-01-02）.